Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
Top Cited Papers
Open Access
- 2 September 2024
- journal article
- review article
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 17 (1) , 1-32
Abstract
Metabolic reprogramming provides tumors with an energy source and biofuel to support their survival in the malignant microenvironment. Extensive research into the intrinsic oncogenic mechanisms of the tumor microenvironment (TME) has established that cancer-associated fibroblast (CAFs) and metabolic reprogramming regulates tumor progression through numerous biological activities, including tumor immunosuppression, chronic inflammation, and ecological niche remodeling. Specifically, immunosuppressive TME formation is promoted and mediators released via CAFs and multiple immune cells that collectively support chronic inflammation, thereby inducing pre-metastatic ecological niche formation, and ultimately driving a vicious cycle of tumor proliferation and metastasis. This review comprehensively explores the process of CAFs and metabolic regulation of the dynamic evolution of tumor-adapted TME, with particular focus on the mechanisms by which CAFs promote the formation of an immunosuppressive microenvironment and support metastasis. Existing findings confirm that multiple components of the TME act cooperatively to accelerate the progression of tumor events. The potential applications and challenges of targeted therapies based on CAFs in the clinical setting are further discussed in the context of advancing research related to CAFs.Keywords
Funding Information
- National Natural Science Foundation of China (82271764, 82171722)
- Natural Science Foundation of Beijing Municipality (7212111)
- National Key Research and Development Program of China (2021YFA0909900)
This publication has 323 references indexed in Scilit:
- Cancer‐Associated Fibroblast‐Induced Remodeling of Tumor Microenvironment in Recurrent Bladder CancerAdvanced Science, 2023
- Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancerThe Journal of Pathology: Clinical Research, 2023
- Cancer‐associated fibroblasts in breast cancer: Challenges and opportunitiesCancer Communications, 2022
- CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenaseHepatology, 2021
- Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma ProgressionHepatology, 2021
- Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapyClinical & Translational Immunology, 2020
- Cancer‐associated fibroblasts promote PD‐L1 expression in mice cancer cells via secreting CXCL5International Journal of Cancer, 2019
- In search of definitions: Cancer‐associated fibroblasts and their markersInternational Journal of Cancer, 2019
- Interaction between IGF2‐PI3K axis and cancer‐associated‐fibroblasts promotes anal squamous carcinogenesisInternational Journal of Cancer, 2019
- Understanding the Bone in Cancer MetastasisJournal of Bone and Mineral Research, 2018